XVIVO: XVIVO Perfusion AB Publishes Annual Report 2023
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today XVIVO Perfusion AB (publ) publish the Annual Report for 2023. The Annual Report is attached to this press release in pdf format and in ESEF format.
Read full article »
XVIVO is a Sweden-based medical technology company that develops optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation.
Read more